Ribonaut Therapeutics
Jupiter, US · Founded 2022
Biotech
Founders & leadership
ZC
Zachary CollinsExecutive Officer
ST
Steven TregayDirector
MD
Matthew DisneyExecutive Officer, Director
LL
Lusong LuoDirector
Reported raises · per SEC filings
Form D private placements▶$6.9MraisedJan 2023 · 6 investors · BiotechnologyRule 506(b)
▶$6.9MraisedJan 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary CollinsExecutive Officer
- Steven TregayDirector
- Matthew DisneyExecutive Officer, Director
- Lusong LuoDirector
- Jessica Childs-DisneyPromoter
- Offering amount
- $26M
- Amount sold
- $6.9M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.